Associations between circulating inflammatory markers and residual renal function in CRF patients

American Journal of Kidney Diseases

Volumn 41, Issue 6, 2003, Pages 1212-1218

  Pecoits Filho, Roberto ^b   Heimbürger, Olof ^b   Bárány, Peter ^b   Suliman, Mohamed ^b   Fehrman Ekholm, Ingela ^b   Lindholm, Bengt ^b   Stenvinkel, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Chronic renal failure (CRF); Cytokines; Glomerular filtration rate (GFR); Inflammation; Renal function

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; HYALURONIC ACID; INTERLEUKIN 6; NEOPTERIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CORRELATION ANALYSIS; CYTOKINE RELEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOPATHOLOGY; INFLAMMATION; KIDNEY CLEARANCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; UREMIA;

EID: 0038100467     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(03)00353-6     Document Type: Article

References (37)

1. Ridker PM, Cushman M, Stampfer MJ, Russell PT, Hennekens CH: Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979, 1997
2. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648-658, 1999
3. Qureshi AR, Alvestrand A, Divino-Filho JC, et al: Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 13:S28-S36, 2002 (suppl 1)
4. Foley RN, Parfrey PS, Harnett JD, et al: Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol 5:728-736, 1996
5. Bologa RM, Levine DM, Parker TS, et al: Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 32:107-114, 1998
6. Pecoits-Filho R, Bárány P, Lindholm B, Heimbürger O, Stenvinkel P: Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 17:1684-1688, 2002
7. Stenvinkel P, Heimbürger O, Wang T, et al: High serum hyaluronan indicates poor survival in renal replacement therapy. Am J Kidney Dis 34:1083-1088, 1999
8. Rauchhaus M, Doehner W, Francis DP, et al: Plasma cytokine parameters and mortality in patients with chroniC heart failure. Circulation 102:3060-3067, 2000
9. Aukrust P, Liabakk NB, Muller F, et al: Serum levels of tumor necrosis factor-alpha (TNF-α) and soluble TNF receptors in human immunodeficiency virus type I infection - Correlations to clinical, immunologic, and virologic parameters. J Infect Dis 169:420-424, 1994
10. Caenazzo A, Pietrogrande F, Sgarabotto D, et al: Serum neopterin levels in haematological malignancies. Haematologica 78:225-229, 1993
11. Kimmel PL, Phillips TM, Simmens SJ, et al: Immunologic function and survival in hemodialysis patients. Kidney Int 54:236-244, 1998
12. van Riemsdijk-van Overbeeke IC, Baan CC, Hesse CJ, et al: TNF-α: mRNA, plasma protein levels and soluble receptors in patients with chronic hemodialysis, on CAPD and with end-stage renal failure. Clin Nephrol 53:115-123, 2000
13. Pereira BJ, Shapiro L, King AJ, et al: Plasma levels of IL-1-β, TNF-α and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 45:890-896, 1994
14. Descamps-Latscha B, Herbelin A, Nguyen AT, et al: Balance between IL-β, TNF-α, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. J Immunol 154:882-892, 1995
15. National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Am J Kidney Dis 39:S1-S246, 2002 (suppl 1)
16. Panichi V, Migliori M, De Pietro S, et al: C-Reactive protein in patients with chronic renal diseases. Ren Fail 23:551-562, 2001
17. Yeun JY, Levine RA, Mantadilok V, Kaysen GA: C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35:469-476, 2000
18. Stenvinkel P, Heimbürger O, Paultre F, et al: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55:1899-1911, 1999
19. Kaysen GA, Dublin JA, Müller HG, Rosales LM, Levin NW: The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. Kidney Int 58:346-352, 2000
20. Van Tellingen A, Grooteman MP, Schoorl M, et al: Intercurrent clinical events are predictive of plasma C-reactive protein levels in hemodialysis patients. Kidney Int 62:632-638, 2002
21. Memoli B, Postiglione L, Cianciaruso B, et al: Role of different dialysis membranes in the release of interleukin-6 soluble receptor in uremic patients. Kidney Int 58:417-424, 2000
22. Jacobson SH, Lu Y, Brauner A: Soluble interleukin-6 receptor, interleukin-10 and granulocyte colony-stimulating factor in acute pyelonephritis: Relationship to markers of bacterial virulence and renal function. Nephron 80:401-407, 1998
23. Svensson M, Yu ZW, Eriksson JW: A small reduction in glomerular filtration is accompanied by insulin resistance in type I diabetes patients with diabetic nephrophathy. Eur J Clin Invest 32:100-109, 2002
24. Bemelmans MH, Gouma DJ, Buurman WA: Influence of nephrectomy on tumor necrosis factor clearance in murine model. J Immunol 150:2007-2017, 1993
25. Hession C, Decker JM, Sherblom AP, et al: Uromodulin (Tamm-Horsfall glycoprotein): A renal ligand for lymphokines. Science 237:1479-1484, 1987
26. Bolton CH, Downs LG, Victory JG, et al: Endothelial dysfunction in chronic renal failure: Roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant 16:1189-1197, 2001
27. Espinoza M, Aguilera A, Auxiliadora Bajo M, et al: Tumor necrosis factor alpha as a uremic toxin: Correlation with neuropathy, left ventricular hypertrophy, anemia, and hypertriglyceridemia in peritoneal dialysis patients. Adv Perit Dial 15:82-86, 1999
28. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9:S 16-S23, 1998 (suppl 12)
29. Wang AY, Wang M, Woo J, et al: A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int 62:639-647, 2002
30. Chung SH, Heimbürger O, Stenvinkel P, Bergström J, Lindholm B: Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. Nephrol Dial Transplant 16:2240-2245, 2001
31. Niebauer J, Volk H-D, Kemp M, et al: Endotoxin and immune activation in chronic heart failure: A prospective cohort study. Lancet 353:1838-1842, 1999
32. Miyata T, Ueda Y, Shinzato T, et al: Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: Renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol 7:1198-1206, 1996
33. Miyata T, Ishiguro N, Yasuda Y, et al: Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers. Biochem Biophys Res Commun 244:45-49, 1998
34. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM: The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62:1524-1538, 2002
35. Vanholder R, Argiles A, Baurmeister U, et al: Uremic toxicity: Present state of the art. Int J Artif Organs 24:695-725, 2001
36. Wang T, Ye RG, Zhen ZH, Li HQ, Mai WY: Influence of peritoneal dialysis on the progression of chronic renal failure. Adv Perit Dial 11:139-141, 1995
37. Pecoits-Filho R, Heimbürger O, Lindholm B, Bárány B, Stenvinkel P: Interleukin-6 system is associated with renal function in end-stage renal disease. Blood Purif 20:511A, 2002 (abstr)